Logo image of EXL.DE

EXASOL AG (EXL.DE) Stock Fundamental Analysis

FRA:EXL - Deutsche Boerse Ag - DE000A0LR9G9 - Common Stock - Currency: EUR

3.14  +0.16 (+5.37%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to EXL. EXL was compared to 101 industry peers in the Software industry. No worries on liquidiy or solvency for EXL as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, EXL is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

EXL had negative earnings in the past year.
EXL had a positive operating cash flow in the past year.
EXL had negative earnings in each of the past 5 years.
In the past 5 years EXL reported 4 times negative operating cash flow.
EXL.DE Yearly Net Income VS EBIT VS OCF VS FCFEXL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 -10M -20M -30M -40M

1.2 Ratios

The Return On Assets of EXL (-13.15%) is worse than 72.28% of its industry peers.
Looking at the Return On Equity, with a value of -85.77%, EXL is doing worse than 77.23% of the companies in the same industry.
Industry RankSector Rank
ROA -13.15%
ROE -85.77%
ROIC N/A
ROA(3y)-58.8%
ROA(5y)-52.5%
ROE(3y)-205.01%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EXL.DE Yearly ROA, ROE, ROICEXL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 100 -100 -200

1.3 Margins

EXL's Gross Margin of 94.02% is amongst the best of the industry. EXL outperforms 94.06% of its industry peers.
In the last couple of years the Gross Margin of EXL has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for EXL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 94.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.89%
GM growth 5Y-1.41%
EXL.DE Yearly Profit, Operating, Gross MarginsEXL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 50 -50 -100

More info and screens

7

2. Health

2.1 Basic Checks

EXL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for EXL has been increased compared to 1 year ago.
The number of shares outstanding for EXL has been increased compared to 5 years ago.
There is no outstanding debt for EXL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EXL.DE Yearly Shares OutstandingEXL.DE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
EXL.DE Yearly Total Debt VS Total AssetsEXL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

EXL has an Altman-Z score of 2.95. This is not the best score and indicates that EXL is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.95, EXL is in line with its industry, outperforming 58.42% of the companies in the same industry.
There is no outstanding debt for EXL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.95
ROIC/WACCN/A
WACC7.6%
EXL.DE Yearly LT Debt VS Equity VS FCFEXL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M

2.3 Liquidity

A Current Ratio of 29.92 indicates that EXL has no problem at all paying its short term obligations.
EXL's Current ratio of 29.92 is amongst the best of the industry. EXL outperforms 100.00% of its industry peers.
EXL has a Quick Ratio of 29.92. This indicates that EXL is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 29.92, EXL belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 29.92
Quick Ratio 29.92
EXL.DE Yearly Current Assets VS Current LiabilitesEXL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

5

3. Growth

3.1 Past

EXL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 80.52%, which is quite impressive.
The Revenue has been growing slightly by 5.66% in the past year.
Measured over the past years, EXL shows a quite strong growth in Revenue. The Revenue has been growing by 14.68% on average per year.
EPS 1Y (TTM)80.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.31%
Revenue 1Y (TTM)5.66%
Revenue growth 3Y14.2%
Revenue growth 5Y14.68%
Sales Q2Q%9.35%

3.2 Future

Based on estimates for the next years, EXL will show a very strong growth in Earnings Per Share. The EPS will grow by 34.74% on average per year.
EXL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.21% yearly.
EPS Next Y96.92%
EPS Next 2Y46.23%
EPS Next 3Y34.74%
EPS Next 5YN/A
Revenue Next Year7.46%
Revenue Next 2Y6.89%
Revenue Next 3Y7.59%
Revenue Next 5Y13.21%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
EXL.DE Yearly Revenue VS EstimatesEXL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 20M 40M 60M 80M 100M
EXL.DE Yearly EPS VS EstimatesEXL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EXL. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 69.09, the valuation of EXL can be described as expensive.
EXL's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.10. EXL is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 69.09
EXL.DE Price Earnings VS Forward Price EarningsEXL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

EXL's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 100.84
EV/EBITDA N/A
EXL.DE Per share dataEXL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EXL's earnings are expected to grow with 34.74% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.23%
EPS Next 3Y34.74%

More info and screens

0

5. Dividend

5.1 Amount

EXL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EXASOL AG

FRA:EXL (3/7/2025, 7:00:00 PM)

3.14

+0.16 (+5.37%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-13 2024-11-13
Earnings (Next)03-18 2025-03-18/amc
Inst Owners16.97%
Inst Owner ChangeN/A
Ins Owners3.72%
Ins Owner ChangeN/A
Market Cap84.40M
Analysts83.33
Price Target4.85 (54.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.26%
PT rev (3m)4.4%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)60%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.25%
Revenue NY rev (3m)-1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 69.09
P/S 2.29
P/FCF 100.84
P/OCF 81
P/B 20.68
P/tB 63.05
EV/EBITDA N/A
EPS(TTM)-0.12
EYN/A
EPS(NY)0.05
Fwd EY1.45%
FCF(TTM)0.03
FCFY0.99%
OCF(TTM)0.04
OCFY1.23%
SpS1.37
BVpS0.15
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.15%
ROE -85.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 94.02%
FCFM 2.27%
ROA(3y)-58.8%
ROA(5y)-52.5%
ROE(3y)-205.01%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.89%
GM growth 5Y-1.41%
F-Score6
Asset Turnover1.38
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 8.87%
Cap/Sales 0.56%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 29.92
Quick Ratio 29.92
Altman-Z 2.95
F-Score6
WACC7.6%
ROIC/WACCN/A
Cap/Depr(3y)57.12%
Cap/Depr(5y)72.1%
Cap/Sales(3y)5.78%
Cap/Sales(5y)8.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)80.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.31%
EPS Next Y96.92%
EPS Next 2Y46.23%
EPS Next 3Y34.74%
EPS Next 5YN/A
Revenue 1Y (TTM)5.66%
Revenue growth 3Y14.2%
Revenue growth 5Y14.68%
Sales Q2Q%9.35%
Revenue Next Year7.46%
Revenue Next 2Y6.89%
Revenue Next 3Y7.59%
Revenue Next 5Y13.21%
EBIT growth 1Y75.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year120.25%
EBIT Next 3Y39.51%
EBIT Next 5YN/A
FCF growth 1Y103.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y104.44%
OCF growth 3YN/A
OCF growth 5YN/A